Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: NHS England agrees additional funding for new drugs `early access` scheme


Guru

Status: Offline
Posts: 5629
Date:
NHS England agrees additional funding for new drugs `early access` scheme
Permalink  
 


NHS England agrees funding for new drug treatments for Hep C totalling almost a quarter of a billion pounds.

In what will be the NHS` single largest investment in new treatments this year, NHS England has today (10 June 2015) announced it will be investing an estimated further £190 million in new cures for hepatitis C, on top of the approximately £40 million extra which began last year.

The widening of NHS England`s `early access` scheme to patients with cirrhosis will see an expected additional 3,500 patients accessing treatment in this year, representing an additional investment of around £190m. This is additional to the new funding introduced last year for patients at imminent risk of liver failure, benefiting around 1000 people so far.

Richard Jeavons, NHS England`s Director of Specialised Services, said: "At a time when funding is inevitably constrained across the NHS this is a huge new investment; in fact it`ll be the NHS` single largest new treatment expansion this year. That`s why we`re also running a competitive tendering process in parallel, to seek to bring down the price of these very expensive new drugs."

 

Full article..

http://hepctrust.org.uk/news/jun-2015/thousands-more-patients-be-cured-hepatitis-



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.